CEFPROZIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cefprozil, and when can generic versions of Cefprozil launch?
Cefprozil is a drug marketed by Apotex Inc, Aurobindo Pharma, Chartwell Rx, Lupin, Orchid Hlthcare, Ranbaxy Labs Ltd, Sandoz, Teva, and Wockhardt. and is included in fifteen NDAs.
The generic ingredient in CEFPROZIL is cefprozil. There are thirteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the cefprozil profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cefprozil
A generic version of CEFPROZIL was approved as cefprozil by CHARTWELL RX on November 14th, 2005.
Summary for CEFPROZIL
| US Patents: | 0 |
| Applicants: | 9 |
| NDAs: | 15 |
| Finished Product Suppliers / Packagers: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 55 |
| Clinical Trials: | 14 |
| Patent Applications: | 5,673 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for CEFPROZIL |
| DailyMed Link: | CEFPROZIL at DailyMed |
Recent Clinical Trials for CEFPROZIL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| The Affiliated Hospital of Qingdao University | Phase 1 |
| University of Louisville | Early Phase 1 |
| James Graham Brown Cancer Center | Early Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for CEFPROZIL
US Patents and Regulatory Information for CEFPROZIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva | CEFPROZIL | cefprozil | TABLET;ORAL | 065208-002 | Dec 6, 2005 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Wockhardt | CEFPROZIL | cefprozil | TABLET;ORAL | 065428-001 | Jun 14, 2007 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Apotex Inc | CEFPROZIL | cefprozil | FOR SUSPENSION;ORAL | 065351-001 | Feb 29, 2012 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Aurobindo Pharma | CEFPROZIL | cefprozil | TABLET;ORAL | 065340-002 | May 24, 2007 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Orchid Hlthcare | CEFPROZIL | cefprozil | TABLET;ORAL | 065267-002 | Dec 19, 2005 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Lupin | CEFPROZIL | cefprozil | FOR SUSPENSION;ORAL | 065261-001 | Dec 19, 2005 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
